Zenas BioPharma, Inc. Common Stock (NASDAQ: ZBIO) last traded at $32.29, up 2.12% on the session. The quote above updates while this page is open; the figures below are drawn from Zenas BioPharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Zenas BioPharma, Inc. Common Stock trades on NASDAQ under the ticker ZBIO. Its market capitalisation is $2.10 billion.
Valuation measures for Zenas BioPharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.10B |
|---|---|
| Enterprise value | $2.36B |
| Price / sales | 210.46 |
| Price / book | 8.52 |
| Beta | 0.79 |
Trailing-twelve-month figures tagged in Zenas BioPharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.00M |
|---|---|
| Net income (TTM) | -$484.38M |
| EPS (TTM) | -$9.62 |
| Operating margin | -4755.73% |
| Return on equity | -196.03% |
| Cash | $196.58M |
Range and volume for ZBIO over the past 52 weeks.
| 52-week high | $44.60 |
|---|---|
| 52-week low | $13.50 |
| Volume | 746.7K |
| Average volume | 841.9K |
| Previous close | $31.62 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.